Find out what you need to know about prokinetic agents, and discover the pros, cons, risks, and benefits, and how they may affect health.

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) is among the fundamentally strong penny stocks to invest in. Analysts at H.C.

Prokinetic drugs Most patients with gastroparesis require drug therapy, and for most this needs to continue long term.

To date, six other meta-analyses of prokinetic agents for treatment of FD have been reported ( Table 2). [43,44,45,46,47,48] In terms of the agents investigated and the scope of the literature ...

Medically reviewed by Lindsay Cook, PharmD Several available over-the-counter (OTC) and prescription drugs can help manage ...

Studies on prokinetic agents, including metoclopramide, domperidone, trimebutine, cisapride, itopride and mosapride, in patients with FD were identified by computerized and manual searches of the ...

Many common drugs, including some prokinetic, antibiotic and anti-psychotic medications, can change how the heart’s electrical system functions.

Prokinetic agents produce an increase in LES tone, which, along with acid suppression, plays a key role in bringing reflux under control. Cisapride, a prokinetic agent currently obtainable only ...

Cidine is a gastrointestinal prokinetic agent discovered by Almirall, S.A. Under the terms of a license agreement signed with Almirall in March 2010, Eisai obtained from Almirall the exclusive ...

TZP-102 is a novel, orally administered prokinetic agent that acts by a mechanism distinct from previously developed products for gastrointestinal (GI) motility disorders.

Prokinetics (metoclopramide) Two studies involved prokinetic agents for anorexia. 38, 39 Fifty-five patients were included. Metoclopramide 80 mg/d administered orally was used, and the study duration ...